Sun, Ashley
Tsamis, Emmanouil
Eguia, Melvi D.
Liebmann, Jeffrey M.
Blumberg, Dana M.
Al-Aswad, Lama A.
Cioffi, George A.
Gustavo De Moraes, C.
Hood, Donald C.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY-02115)
Article History
Received: 13 July 2020
Revised: 26 September 2020
Accepted: 5 November 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: ET: Topcon (R); JML: Heidelberg Eng (C, S); Carl Zeiss (C); Topcon (C); LA-A: New World Medical (F); Save Vision Foundation (F); Topcon (F); Carl Zeiss (F); Globechek (I); Aries (C); Google (C); CGDM: Carl Zeiss (C); Perfuse Therapeutics (C); Novartis (C); Galimedix (C); Belite (C); Reichert (C); Research to Prevent Blindness (R); Heidelberg Eng (R); Topcon (R); National Institutes of Health (R); DCH: Heidelberg Eng (C, F, R); Topcon (C, F, R); Novartis (C, F).